Jennifer LaFemina to Middle Aged
This is a "connection" page, showing publications Jennifer LaFemina has written about Middle Aged.
Connection Strength
0.249
-
Hendrix RJ, Lee C, Friedrich AK, Rouanet E, Larkin AC, LaFemina J. Prophylactic Versus Therapeutic Mastectomy: A Contemporary Analysis of the ACS-NSQIP Database. Clin Breast Cancer. 2019 06; 19(3):e428-e432.
Score: 0.048
-
Cohen J, Meunier R, Jamshed S, Karam AR, Yates J, Wang X, LaFemina J. Metastatic Renal Cell Carcinoma in a Hepatic Hemangioma: A Case Report and Review of the Literature. Int J Surg Pathol. 2016 Sep; 24(6):552-5.
Score: 0.039
-
Lim PW, Dinh KH, Sullivan M, Wassef WY, Zivny J, Whalen GF, LaFemina J. Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resection. HPB (Oxford). 2016 Apr; 18(4):360-6.
Score: 0.039
-
LaFemina J, Qin LX, Moraco NH, Antonescu CR, Fields RC, Crago AM, Brennan MF, Singer S. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors. Ann Surg Oncol. 2013 Jan; 20(1):66-72.
Score: 0.031
-
LaFemina J, Vagefi PA, Warshaw AL, Fern?ndez-del Castillo C. Transgastric pancreaticogastric anastomosis: an alternative operative approach for middle pancreatectomy. Arch Surg. 2010 May; 145(5):476-81.
Score: 0.026
-
Barth RJ, Mills JB, Suriawinata AA, Putra J, Tosteson TD, Axelrod D, Freeman R, Whalen GF, LaFemina J, Tarczewski SM, Kinlaw WB. Short-term Preoperative Diet Decreases Bleeding After Partial Hepatectomy: Results From a Multi-institutional Randomized Controlled Trial. Ann Surg. 2019 01; 269(1):48-52.
Score: 0.012
-
Laskiewicz L, Jamshed S, Gong Y, Ainechi S, LaFemina J, Wang X. The diagnostic value of FNA biopsy in grading pancreatic neuroendocrine tumors. Cancer Cytopathol. 2018 03; 126(3):170-178.
Score: 0.011
-
Dinh KH, Harris AF, LaFemina J, Whalen GF, Sullivan M, Licho R, Hill T, Lambert LA. Advantages of day-before lymphoscintigraphy and undiluted methylene blue dye injections for sentinel lymph node biopsies for melanoma. J Surg Oncol. 2016 Dec; 114(8):947-950.
Score: 0.010
-
Tan MC, Basturk O, Brannon AR, Bhanot U, Scott SN, Bouvier N, LaFemina J, Jarnagin WR, Berger MF, Klimstra D, Allen PJ. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. J Am Coll Surg. 2015 May; 220(5):845-854.e1.
Score: 0.009
-
Do RK, Katz SS, Gollub MJ, Li J, LaFemina J, Zabor EC, Moskowitz CS, Klimstra DS, Allen PJ. Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT. AJR Am J Roentgenol. 2014 Nov; 203(5):973-9.
Score: 0.009
-
Correa-Gallego C, Do R, Lafemina J, Gonen M, D'Angelica MI, DeMatteo RP, Fong Y, Kingham TP, Brennan MF, Jarnagin WR, Allen PJ. Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. Ann Surg Oncol. 2013 Dec; 20(13):4348-55.
Score: 0.008
-
Fritz S, Fern?ndez-del Castillo C, Iafrate AJ, Mino-Kenudson M, Neyhard N, LaFemina J, Stirman A, Warshaw AL, Thayer SP. Novel xenograft and cell line derived from an invasive intraductal papillary mucinous neoplasm of the pancreas give new insights into molecular mechanisms. Pancreas. 2010 Apr; 39(3):308-14.
Score: 0.007